NIF SMBC Ventures
12
18M
8
1
0.33
6
- Stages of investment
- Areas of investment
Summary
The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the Palo Alto.
Among the most popular portfolio startups of the fund, we may highlight Novexel, Diatos, REGiMMUNE Corporation. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Therapeutics, Computer. For fund there is no match between the location of its establishment and the land of its numerous investments - France.
The real fund results show that this VC is 0 percentage points less often commits exit comparing to other companies. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top amount of exits for fund were in 2009. The important activity for fund was in 2007. Opposing the other organizations, this NIF SMBC Ventures works on 11 percentage points more the average amount of lead investments. The fund is generally included in less than 2 deals every year.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the NIF SMBC Ventures, startups are often financed by Sofinnova Partners, Japan Asia Investment, Crosspoint Venture Partners. The meaningful sponsors for the fund in investment in the same round are Japan Asia Investment, Yasuda Enterprise Development, Sofinnova Partners. In the next rounds fund is usually obtained by Japan Asia Investment, Yasuda Enterprise Development, SMBC Venture Capital.
Investments analytics
Analytics
- Total investments
- 12
- Lead investments
- 1
- Exits
- 6
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (10)
- Biopharma (6)
- Medical (4)
- Health Diagnostics (4)
- Health Care (3) Show 9 more
- Investments by region
-
- France (5)
- Japan (5)
- United States (1)
- Australia (1)
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 20
- Avg. valuation at time of investment
- 50M
- Group Appearance index
- 1.00
- Avg. company exit year
- 12
- Avg. multiplicator
- 0.94
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Abionyx Pharma | 12 Nov 2006 | Biotechnology, Health Care | Early Stage Venture | 53M | Midi-Pyrenees, Balma, France |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.